![\"\"](\"https:\/\/www.sandiegochinesepress.com\/press\/wp-content\/uploads\/2019\/10\/DE61ECC8-2D45-4E66-B1B6-A448A5327F14-e1570978598355.png\")
<\/a><\/p>\n\u25b2Reyvow\u57283\u671f\u4e34\u5e8a\u8bd5\u9a8c\u4e2d\u7684\u90e8\u5206\u7597\u6548\u7ed3\u679c\uff08\u56fe\u7247\u6765\u6e90\uff1a\u53c2\u8003\u8d44\u6599[3]\uff09<\/p>\n
\u201c\u4e0a\u767e\u4e07\u504f\u5934\u75db\u60a3\u8005\u6bcf\u5929\u8981\u4e0e\u65e0\u6cd5\u6d88\u9664\u7684\u75bc\u75db\u548c\u5176\u5b83\u504f\u5934\u75db\u75c7\u72b6\u4f5c\u6597\u4e89\u3002\u5728\u504f\u5934\u75db\u6025\u6027\u6cbb\u7597\u65b9\u9762\u4ecd\u7136\u5b58\u5728\u5f88\u5927\u672a\u7adf\u9700\u6c42\u3002\u4eca\u5929\u7684\u6279\u51c6\u8ba9\u6211\u4eec\u611f\u5230\u975e\u5e38\u81ea\u8c6a\uff0c\u793c\u6765\u5c06\u7ee7\u7eed\u4e3a\u504f\u5934\u75db\u60a3\u8005\u9020\u798f\uff0c\u201d\u793c\u6765\u751f\u7269\u533b\u836f\u795e\u7ecf\u79d1\u5f00\u53d1\u526f\u603b\u88c1Gudarz Davar\u535a\u58eb\u8bf4\uff1a\u201c\u5728\u6cbb\u7597\u504f\u5934\u75db\u65b9\u9762\u6211\u4eec\u6709\u4e86\u65b0\u7684\u671f\u671b\u503c\uff0c\u65e0\u75db\u662f\u504f\u5934\u75db\u60a3\u8005\u548c\u533b\u5e08\u4eec\u7684\u6cbb\u7597\u76ee\u6807\u3002\u793c\u6765\u5c06\u7ee7\u7eed\u5f00\u53d1\u521b\u65b0\u4ea7\u54c1\uff0c\u4e3a\u504f\u5934\u75db\u60a3\u8005\u63d0\u4f9b\u65b0\u7684\u6cbb\u7597\u9009\u62e9\u3002\u201d<\/p>\n
\u53c2\u8003\u8d44\u6599\uff1a<\/p>\n
[1] FDA approves new treatment for patients with migraine. Retrieved October 11, 2019, from https:\/\/www.prnewswire.com\/news-releases\/fda-approves-new-treatment-for-patients-with-migraine-300937273.html
\n[2] Lilly’s REYVOW™ (lasmiditan), The First and Only Medicine in a New Class of Acute Treatment for Migraine, Receives FDA Approval. Retrieved October 11, 2019, from https:\/\/www.prnewswire.com\/news-releases\/lillys-reyvow-lasmiditan-the-first-and-only-medicine-in-a-new-class-of-acute-treatment-for-migraine-receives-fda-approval-300937322.html
\n[3] 2018 Investment Community Meeting. Retrieved October 11, 2019, from https:\/\/investor.lilly.com\/static-files\/e1cc74de-ada5-4ae4-b5a4-7ecf0969197d
\n[4] Lilly Submits New Drug Application to the FDA for Lasmiditan for Acute Treatment of Migraine, Receives Breakthrough Therapy Designation for Emgality™ (galcanezumab-gnlm) for Prevention of Episodic Cluster Headache. Retrieved October 11, 2019, from https:\/\/investor.lilly.com\/news-releases\/news-release-details\/lilly-submits-new-drug-application-fda-lasmiditan-acute
\n[5] Therapeutic novelties in migraine: new drugs, new hope? Retrieved October 11, 2019, from https:\/\/doi.org\/10.1186\/s10194-019-0974-3<\/p>\n","protected":false},"excerpt":{"rendered":"
20\u5e74\u6765\u6025\u6027\u6cbb\u7597\u504f\u5934\u75db\u9996\u4e2a\u91cd\u5927\u521b\u65b0\u3002\u793c\u6765\uff08Lilly\uff09\u516c\u53f8\u5ba3\u5e03\uff0c\u7f8e\u56fdFDA\u6279\u51c6\u8be5\u516c\u53f8\u5f00\u53d1\u7684Reyvow\uff08lasmiditan\uff09\u7247\u5242\u4e0a\u5e02\uff0c\u4f5c\u4e3a\u6025\u6027\u7597\u6cd5\u6cbb\u7597\u6709\u5148\u5146\u6216\u65e0\u5148\u5146\u6210\u5e74\u504f\u5934\u75db\u60a3\u8005\u3002\u3002\u3002\u3002\u3002<\/p>\n","protected":false},"author":3,"featured_media":1457156,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[16],"tags":[],"class_list":["post-1457151","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-science_technology_education"],"_links":{"self":[{"href":"https:\/\/www.sandiegochinesepress.com\/press\/wp-json\/wp\/v2\/posts\/1457151","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.sandiegochinesepress.com\/press\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.sandiegochinesepress.com\/press\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.sandiegochinesepress.com\/press\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.sandiegochinesepress.com\/press\/wp-json\/wp\/v2\/comments?post=1457151"}],"version-history":[{"count":0,"href":"https:\/\/www.sandiegochinesepress.com\/press\/wp-json\/wp\/v2\/posts\/1457151\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.sandiegochinesepress.com\/press\/wp-json\/wp\/v2\/media\/1457156"}],"wp:attachment":[{"href":"https:\/\/www.sandiegochinesepress.com\/press\/wp-json\/wp\/v2\/media?parent=1457151"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.sandiegochinesepress.com\/press\/wp-json\/wp\/v2\/categories?post=1457151"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.sandiegochinesepress.com\/press\/wp-json\/wp\/v2\/tags?post=1457151"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
![\"\"](\"https:\/\/www.sandiegochinesepress.com\/press\/wp-content\/uploads\/2019\/10\/35F46CE4-E3FF-4D94-AEE2-74ED4AD00781.png\")
<\/a><\/p>\n